Bio Path Holdings Stock Market Value
| BPTH Stock | USD 0.80 0.02 2.44% |
| Symbol | Bio |
Bio Path Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.34) | Return On Assets (1.40) | Return On Equity (3.66) |
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bio Path 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Path's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Path.
| 05/30/2024 |
| 11/26/2024 |
If you would invest 0.00 in Bio Path on May 30, 2024 and sell it all today you would earn a total of 0.00 from holding Bio Path Holdings or generate 0.0% return on investment in Bio Path over 180 days. Bio Path is related to or competes with Capricor Therapeutics, NextCure, Pulmatrix, Crinetics Pharmaceuticals, Aileron Therapeutics, Benitec Biopharma, and Moleculin Biotech. Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug developmen... More
Bio Path Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Path's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Path Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 51.22 | |||
| Value At Risk | (8.08) | |||
| Potential Upside | 6.67 |
Bio Path Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Path's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Path's standard deviation. In reality, there are many statistical measures that can use Bio Path historical prices to predict the future Bio Path's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (1.47) | |||
| Treynor Ratio | 5.61 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Path's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Path Holdings Backtested Returns
Bio Path Holdings secures Sharpe Ratio (or Efficiency) of -0.0165, which signifies that the company had a -0.0165% return per unit of risk over the last 3 months. Bio Path Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bio Path's Standard Deviation of 6.75, mean deviation of 4.04, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0749, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bio Path are expected to decrease at a much lower rate. During the bear market, Bio Path is likely to outperform the market. At this point, Bio Path Holdings has a negative expected return of -0.11%. Please make sure to confirm Bio Path's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Bio Path Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
Bio Path Holdings has below average predictability. Overlapping area represents the amount of predictability between Bio Path time series from 30th of May 2024 to 28th of August 2024 and 28th of August 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Path Holdings price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current Bio Path price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Bio Path Holdings lagged returns against current returns
Autocorrelation, which is Bio Path stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Path's stock expected returns. We can calculate the autocorrelation of Bio Path returns to help us make a trade decision. For example, suppose you find that Bio Path has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Path regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Path stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Path stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Path stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Path Lagged Returns
When evaluating Bio Path's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Path stock have on its future price. Bio Path autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Path autocorrelation shows the relationship between Bio Path stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Path Holdings.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock:Check out Bio Path Correlation, Bio Path Volatility and Bio Path Alpha and Beta module to complement your research on Bio Path. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Bio Path technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.